Sales rise 2.14% to Rs 61.44 crore
Net profit of Jagsonpal Pharmaceuticals declined 28.74% to Rs 5.33 crore in the quarter ended June 2024 as against Rs 7.48 crore during the previous quarter ended June 2023. Sales rose 2.14% to Rs 61.44 crore in the quarter ended June 2024 as against Rs 60.15 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales61.4460.15 2 OPM %16.6814.35 -PBDT11.4710.48 9 PBT10.4010.09 3 NP5.337.48 -29Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Indian Share market, BSE, Stock market")
 "Shaktikanta Das, Shaktikanta, RBI Governor")
 "Algeria's Khelif (Red) and Italy's Carini (Blue) after thier match at 2024 Paris Olympics")
 "Protest, UK Protest, UK Riots")
 "Hunter Biden")
